Hansa Biopharma AB (HNSBF)
3.70
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Hansa Biopharma Gross Profit Margin (Quarterly) : 53.57% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 53.57% |
| March 31, 2026 | 60.14% |
| December 31, 2025 | 67.55% |
| September 30, 2025 | 34.72% |
| June 30, 2025 | 63.33% |
| March 31, 2025 | 69.08% |
| December 31, 2024 | 58.29% |
| September 30, 2024 | 76.62% |
| June 30, 2024 | -18.04% |
| March 31, 2024 | 67.57% |
| December 31, 2023 | 64.04% |
| September 30, 2023 | 27.07% |
| June 30, 2023 | 48.94% |
| March 31, 2023 | 60.13% |
| December 31, 2022 | 85.26% |
| September 30, 2022 | 73.71% |
| June 30, 2022 | 80.77% |
| March 31, 2022 | 62.90% |
| December 31, 2021 | 76.47% |
| September 30, 2021 | -56.35% |
| June 30, 2021 | 48.56% |
| March 31, 2021 | 80.73% |
| December 31, 2020 | 95.48% |
| Date | Value |
|---|---|
| September 30, 2020 | 62.63% |
| June 30, 2020 | 81.37% |
| March 31, 2020 | 52.19% |
| December 31, 2019 | 86.65% |
| September 30, 2019 | 68.09% |
| June 30, 2019 | 83.57% |
| March 31, 2019 | 56.26% |
| December 31, 2018 | 44.84% |
| September 30, 2018 | 89.65% |
| June 30, 2018 | 94.31% |
| March 31, 2018 | 91.45% |
| December 31, 2017 | 94.75% |
| September 30, 2017 | 92.08% |
| June 30, 2017 | 92.26% |
| March 31, 2017 | 94.27% |
| December 31, 2016 | 90.00% |
| September 30, 2016 | 93.98% |
| June 30, 2016 | 90.00% |
| March 31, 2016 | 90.78% |
| December 31, 2015 | 46.29% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | -293.8% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| BioArctic AB | 91.24% |
| Swedish Orphan Biovitrum AB | 61.17% |
| Diamyd Medical AB | -32.07K% |
| BONESUPPORT HOLDING AB | 90.81% |
| BioInvent International AB | 0.00% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -78.68% |
| Return on Invested Capital | -128.2% |
| Profit Margin (Quarterly) | -541.7% |
| Operating Margin (Quarterly) | -334.8% |
| Return on Net Operating Assets | -227.8% |